Vandana Dialani, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 34 | 2024 | 21022 | 1.800 |
Why?
|
Fibroadenoma | 2 | 2021 | 41 | 1.420 |
Why?
|
Mammography | 17 | 2024 | 2449 | 1.410 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 5 | 2023 | 938 | 1.200 |
Why?
|
Radar | 1 | 2021 | 11 | 0.770 |
Why?
|
Breast Diseases | 4 | 2018 | 443 | 0.700 |
Why?
|
Contrast Media | 7 | 2022 | 5302 | 0.670 |
Why?
|
Breast | 9 | 2022 | 1979 | 0.670 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2018 | 35 | 0.620 |
Why?
|
Iohexol | 1 | 2019 | 198 | 0.620 |
Why?
|
Burnout, Professional | 2 | 2024 | 699 | 0.600 |
Why?
|
Biopsy | 8 | 2023 | 6772 | 0.560 |
Why?
|
Magnetic Resonance Imaging | 18 | 2023 | 36160 | 0.550 |
Why?
|
Cryosurgery | 1 | 2021 | 471 | 0.530 |
Why?
|
Lymph Nodes | 3 | 2018 | 3489 | 0.490 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2021 | 1093 | 0.490 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2018 | 517 | 0.470 |
Why?
|
Carcinoma, Lobular | 1 | 2018 | 490 | 0.460 |
Why?
|
Mediastinoscopy | 1 | 2011 | 29 | 0.390 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2019 | 1376 | 0.380 |
Why?
|
Bronchial Diseases | 1 | 2011 | 151 | 0.350 |
Why?
|
Mediastinum | 1 | 2011 | 265 | 0.340 |
Why?
|
Sensitivity and Specificity | 13 | 2022 | 14652 | 0.340 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9269 | 0.340 |
Why?
|
Gynecomastia | 1 | 2010 | 87 | 0.340 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2022 | 2774 | 0.320 |
Why?
|
Physicians | 2 | 2024 | 4586 | 0.310 |
Why?
|
Ultrasonography, Mammary | 3 | 2019 | 247 | 0.300 |
Why?
|
Respiration Disorders | 1 | 2008 | 368 | 0.250 |
Why?
|
Female | 44 | 2024 | 390240 | 0.250 |
Why?
|
Breast Implants | 2 | 2019 | 411 | 0.230 |
Why?
|
Early Detection of Cancer | 5 | 2024 | 3204 | 0.230 |
Why?
|
Neoadjuvant Therapy | 1 | 2015 | 2809 | 0.220 |
Why?
|
Retrospective Studies | 17 | 2021 | 80121 | 0.220 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2004 | 231 | 0.220 |
Why?
|
Pregnancy, Ectopic | 1 | 2004 | 144 | 0.210 |
Why?
|
Bronchoscopy | 1 | 2008 | 902 | 0.210 |
Why?
|
Mass Screening | 4 | 2021 | 5419 | 0.210 |
Why?
|
Epithelial Cells | 1 | 2014 | 3664 | 0.200 |
Why?
|
Receptors, Estrogen | 3 | 2023 | 2201 | 0.190 |
Why?
|
Middle Aged | 26 | 2021 | 219653 | 0.180 |
Why?
|
Humans | 48 | 2024 | 759255 | 0.180 |
Why?
|
Stereotaxic Techniques | 2 | 2014 | 548 | 0.180 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3526 | 0.180 |
Why?
|
Precancerous Conditions | 3 | 2017 | 979 | 0.180 |
Why?
|
Adult | 24 | 2022 | 219390 | 0.180 |
Why?
|
Biopsy, Fine-Needle | 2 | 2018 | 1111 | 0.170 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9374 | 0.170 |
Why?
|
Aged | 20 | 2021 | 168617 | 0.170 |
Why?
|
Predictive Value of Tests | 3 | 2023 | 15264 | 0.170 |
Why?
|
Radiographic Image Enhancement | 2 | 2020 | 881 | 0.160 |
Why?
|
Physicians, Women | 1 | 2024 | 491 | 0.150 |
Why?
|
Papilloma | 1 | 2018 | 141 | 0.150 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2019 | 167 | 0.140 |
Why?
|
Stents | 1 | 2008 | 3308 | 0.140 |
Why?
|
Ultrasonography, Prenatal | 1 | 2004 | 1740 | 0.130 |
Why?
|
Practice Management, Medical | 1 | 2018 | 191 | 0.130 |
Why?
|
Mastectomy, Segmental | 1 | 2021 | 965 | 0.130 |
Why?
|
Sweat Gland Neoplasms | 1 | 2017 | 117 | 0.120 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2019 | 586 | 0.120 |
Why?
|
Vacuum | 1 | 2014 | 66 | 0.120 |
Why?
|
Diagnosis, Differential | 6 | 2022 | 12964 | 0.120 |
Why?
|
Mucocele | 1 | 2015 | 51 | 0.120 |
Why?
|
Breast Implantation | 1 | 2017 | 223 | 0.120 |
Why?
|
Disabled Persons | 1 | 2024 | 1226 | 0.120 |
Why?
|
Receptors, Progesterone | 1 | 2018 | 1122 | 0.110 |
Why?
|
Image Enhancement | 2 | 2015 | 2878 | 0.110 |
Why?
|
Pregnancy Outcome | 1 | 2004 | 2901 | 0.110 |
Why?
|
Patient Preference | 1 | 2021 | 919 | 0.110 |
Why?
|
Needles | 2 | 2018 | 452 | 0.110 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 1217 | 0.110 |
Why?
|
Workflow | 1 | 2018 | 850 | 0.110 |
Why?
|
Incidental Findings | 1 | 2017 | 699 | 0.100 |
Why?
|
Physicians, Primary Care | 1 | 2019 | 623 | 0.100 |
Why?
|
Aged, 80 and over | 10 | 2020 | 58867 | 0.100 |
Why?
|
Patient Positioning | 1 | 2014 | 327 | 0.090 |
Why?
|
Benchmarking | 1 | 2017 | 1040 | 0.090 |
Why?
|
Exudates and Transudates | 1 | 2011 | 175 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5194 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20461 | 0.090 |
Why?
|
Reproducibility of Results | 6 | 2016 | 20031 | 0.090 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2943 | 0.090 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 934 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2750 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 3333 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 2 | 2015 | 4040 | 0.080 |
Why?
|
Continuity of Patient Care | 1 | 2015 | 1060 | 0.080 |
Why?
|
Receptor, erbB-2 | 1 | 2018 | 2524 | 0.080 |
Why?
|
Carcinoma | 1 | 2019 | 2334 | 0.070 |
Why?
|
Insurance Coverage | 1 | 2019 | 1939 | 0.070 |
Why?
|
Observer Variation | 3 | 2020 | 2596 | 0.070 |
Why?
|
Palate, Soft | 1 | 2006 | 100 | 0.070 |
Why?
|
Pandemics | 2 | 2023 | 8609 | 0.070 |
Why?
|
Massachusetts | 1 | 2019 | 8788 | 0.070 |
Why?
|
Pilot Projects | 1 | 2019 | 8540 | 0.060 |
Why?
|
Calcinosis | 1 | 2014 | 1477 | 0.060 |
Why?
|
Cerebral Ventricles | 1 | 2007 | 543 | 0.060 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2004 | 81 | 0.060 |
Why?
|
Patient Care Team | 1 | 2015 | 2510 | 0.060 |
Why?
|
Cerebrospinal Fluid | 1 | 2007 | 542 | 0.060 |
Why?
|
Craniofacial Abnormalities | 1 | 2006 | 315 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2014 | 2309 | 0.060 |
Why?
|
Prenatal Diagnosis | 2 | 2007 | 1260 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6436 | 0.050 |
Why?
|
Laparotomy | 1 | 2004 | 468 | 0.050 |
Why?
|
Corpus Callosum | 1 | 2006 | 749 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7514 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4312 | 0.050 |
Why?
|
Adolescent | 3 | 2019 | 87560 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12800 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2015 | 4359 | 0.040 |
Why?
|
Time Factors | 2 | 2019 | 40109 | 0.040 |
Why?
|
Fetus | 1 | 2006 | 1865 | 0.040 |
Why?
|
Workload | 1 | 2024 | 842 | 0.040 |
Why?
|
Young Adult | 3 | 2019 | 58483 | 0.040 |
Why?
|
Organoids | 1 | 2023 | 729 | 0.040 |
Why?
|
Apocrine Glands | 1 | 2017 | 32 | 0.040 |
Why?
|
Ultrasonography | 1 | 2010 | 5955 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 698 | 0.030 |
Why?
|
Cesarean Section | 1 | 2004 | 1387 | 0.030 |
Why?
|
Gestational Age | 1 | 2004 | 3561 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2017 | 15672 | 0.030 |
Why?
|
Male | 6 | 2024 | 358719 | 0.030 |
Why?
|
Prognosis | 1 | 2015 | 29561 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 13946 | 0.030 |
Why?
|
Hyperplasia | 1 | 2017 | 1158 | 0.030 |
Why?
|
Efficiency, Organizational | 1 | 2018 | 694 | 0.030 |
Why?
|
Fibroblasts | 1 | 2023 | 4084 | 0.030 |
Why?
|
Menopause | 1 | 2020 | 1640 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 22019 | 0.030 |
Why?
|
Age Factors | 2 | 2020 | 18394 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3810 | 0.020 |
Why?
|
Patient Care | 1 | 2015 | 624 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2364 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 54204 | 0.020 |
Why?
|
Mastectomy | 1 | 2015 | 1834 | 0.020 |
Why?
|
Prevalence | 2 | 2015 | 15641 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4527 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3317 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2004 | 39216 | 0.010 |
Why?
|
Pregnancy | 1 | 2004 | 29658 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9274 | 0.010 |
Why?
|
Brain | 1 | 2007 | 26863 | 0.010 |
Why?
|
Movement | 1 | 2006 | 1471 | 0.010 |
Why?
|
United States | 2 | 2021 | 72237 | 0.010 |
Why?
|
Child | 1 | 2021 | 79623 | 0.010 |
Why?
|
Risk Factors | 1 | 2015 | 74167 | 0.000 |
Why?
|